The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Beta–Adrenergic Antagonists in the Prevention of Gastrointestinal Rebleeding in Patients With Cirrhosis: A Meta–Analysis
Abstract
A meta–analysis of 12 selected randomized trials was performed to assess the efficacy of beta–blockers in the prevention of rebleeding and the effect on long–term survival in patients with cirrhosis. Five end points were assessed: rebleeding, variceal rebleeding, death, death from bleeding, and adverse events. Analyses were performed according to the intention–to–treat method. For each end point, heterogeneity and treatment efficacy were assessed by the Der Simonian and Peto methods. When a significant difference was observed, sensitivity analyses were performed by successive stratifications according to treatment duration, cause of initial bleeding, use of placebo, type of beta–blocker, type of publication, certainty of randomization, severity of cirrhosis, interval between index bleed and randomization, and methodological quality. Beta–blockers significantly increased the mean percentage of patients free of rebleeding (21% mean improvement rate, CI 95%: 10%–32%, P < .001, relative risk 1.42), the mean percentage of patients free of variceal rebleeding (20% mean improvement rate, CI 95%: 11%–28%, P < .001), the mean survival rate (5.4% mean improvement rate, CI 95%: 0%–11%, P = .05, relative risk 1.27), the mean percentage of patients free of bleeding death (7.4%, CI 95%: 2%–13%, P < .01, relative risk 1.50). Five patients would need to be treated with beta–blockers to prevent one rebleeding episode, 14 treated to prevent one death, and 13 treated to prevent one death from bleeding. There was no significant heterogeneity among studies by both methods of analysis. In patients with esophageal varices, beta–blockers significantly increase the mean percentage of patients free of rebleeding and the mean survival rate at 2 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
Meta-Analyses of Randomized Controlled Trials
Sacks, H. S., Berrier, J., Reitman, D., Ancona-Berk, V. A., & Chalmers, T. C. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702193160806 · Cited by 1,250
The treatment of portal hypertension: A meta-analytic review
D'amico, G., Pagliaro, L., & Bosch, J. (1995) · Hepatology · doi:10.1002/hep.1840220145 · Cited by 1,015
Laine, L., & Cook, D. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-4-199508150-00007 · Cited by 705
Lebrec, D., Poynard, T., Hillon, P., & Benhamou, J.-P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112033052302 · Cited by 517
Self-citationPoynard, T., Calès, P., Pasta, L., Ideo, G., Pascal, J.-P., Pagliaro, L., Lebrec, D., & the Franco–Italian Multicenter Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242202 · Cited by 488
Self-citationPROPRANOLOL—A MEDICAL TREATMENT FOR PORTAL HYPERTENSION?
Lebrec, D., Corbic, M., Nouel, O., et al. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90063-x · Cited by 328
Self-citationBurroughs, A. K., Jenkins, W. J., Sherlock, S., Dunk, A., Walt, R. P., Osuafor, T. O. K., Mackie, S., & Dick, R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312223092502 · Cited by 302
Cited by
Egger, M., Jüni, P., Bartlett, C., Holenstein, F., & Sterne, J. (2003) · Health Technology Assessment · doi:10.3310/hta7010 · Cited by 1,181
Clinical states of cirrhosis and competing risks
D'Amico, G., Morabito, A., D'Amico, M., Pasta, L., Malizia, G., Rebora, P., & Valsecchi, M. G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.020 · Cited by 536
Gastroesophageal Variceal Hemorrhage
Sharara, A. I., & Rockey, D. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003007 · Cited by 425
Meta‐analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome
Poynard, T., Regimbeau, C., & Benhamou, Y. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00937.x · Cited by 406
Self-citationPortal hypertension and variceal bleeding: An AASLD single topic symposium†
Grace, N. D., Groszmann, R. J., Garcia-Tsao, G., Burroughs, A. K., Pagliaro, L., Makuch, R. W., Bosch, J., Stiegmann, G. V., Henderson, M. J., de Franchis, R., et al. (1998) · Hepatology · doi:10.1002/hep.510280339 · Cited by 398
Metadata
- Authors
- Bernard, B., Lebrec, D., Mathurin, P., Opolon, P., & Poynard, T.
- Venue
- Hepatology
- Published
- 1997-01
- Volume
- 25
- Issue
- 1
- Pages
- 63-70
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1993127048
- Cited by
- 256
- References
- 16
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Beta–Adrenergic Antagonists in the Prevention of Gastrointestinal Rebleeding in Patients With Cirrhosis: A Meta–Analysis. https://app.cochat.ai/papers/10.1002/hep.510250112
- The paper
- Bernard, B., Lebrec, D., Mathurin, P., Opolon, P., & Poynard, T. (1997). Beta–Adrenergic Antagonists in the Prevention of Gastrointestinal Rebleeding in Patients With Cirrhosis: A Meta–Analysis. Hepatology. https://doi.org/10.1002/hep.510250112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.